L E A D I N G W I T H O U T C O M E S
"How can I reduce HAI
rates with limited staff
and cost constraints?"
Nozin
®
NOVA
SM
programs help hundreds of
facilities reverse rising MRSA/MSSA HAI rates
with minimal staff , low cost, even net savings.
Our program outcomes show infection rate
reductions at 53% to 100% with savings up
to $1.4 million.
1
We provide tools, service and support. An
assessment that includes a colonization risk
profi le for your facility is the fi rst step.
Start a free assessment at nozin.com/nova
MRSA = methicillin-resistant Staphylococcus aureus, MSSA = methicillin-susceptible Staphylococcus aureus, HAI = Healthcare-Associated Infection. 1. References: nozin.com/clinical-outcomes. Outcomes reported
by actual customers. Your results may vary. Nozin
®
Nasal Sanitizer
®
antiseptic is for nasal decolonization. ©2022 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin
®
, Nasal Sanitizer
®
, NOVA
SM
are
trademarks of Global Life Technologies Corp. Nozin
®
Nasal Sanitizer
®
antiseptic is an OTC topical drug. No claim is made that it has an e ect on any speci c disease. Patent nos.: nozin.com/patents
in Daily
Patient Nasal
Decolonization
#
1
We can help.
